Catheter Precision Inc. (VTAK) support and resistance · rev $1.5M
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
This page maps Catheter Precision Inc. (VTAK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
VTAK currently screens at market cap $3.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VTAK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VTAK quote page for the session range and the stock page for the full model.
Not investment advice.